Javelin Pharmaceuticals (JAV -28.6%) shares plummet after Hospira (HSP +0.5%) announces an...

|About: Javelin Pharmaceuticals, Inc. (JAV)|By:, SA News Editor

Javelin Pharmaceuticals (JAV -28.6%) shares plummet after Hospira (HSP +0.5%) announces an extension of its tender offer to June 2. Javelin disagrees with Hospira's position that the conditions to the tender offer have not been fully satisfied. (PR)